Publications by authors named "Martin Fabani"

Claim this Profile
C
Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy.
Katie Maurer, Cameron Y Park, Shouvik Mani, Mehdi Borji, Florian Raths, Martin Fabani

Sci Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The human noncoding genome defined by genetic diversity.
Julia di Iulio, Istvan Bartha, Emily H M Wong, Hung-Chun Yu, Victor Lavrenko, Martin M Fabani

Nat Genet· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling of Short-Tandem-Repeat Disease Alleles in 12,632 Human Whole Genomes.
Haibao Tang, Ewen F Kirkness, Christoph Lippert, William H Biggs, Martin Fabani

Am J Hum Genet· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep sequencing of 10,000 human genomes.
Amalio Telenti, Levi C T Pierce, William H Biggs, Julia di Iulio, Emily H M Wong, Martin M Fabani

Proc Natl Acad Sci U S A· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Library preparation methodology can influence genomic and functional predictions in human microbiome research.
Marcus B Jones, Sarah K Highlander, Ericka L Anderson, Weizhong Li, Mark Dayrit, Martin M Fabani

Proc Natl Acad Sci U S A· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs.
Adrian G Torres, Martin M Fabani, Elena Vigorito, Donna Williams, Naowras Al-Obaidi

Nucleic Acids Res· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-selective artificial ribonucleases: oligonucleotide conjugates containing multiple imidazole residues in the catalytic domain.
Natalia G Beloglazova, Martin M Fabani, Nikolai N Polushin, Vladimir V Sil'nikov, Valentin V Vlassov

J Nucleic Acids· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection.
Adrian G Torres, Martin M Fabani, Elena Vigorito, Michael J Gait

RNA· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PNA-peptide conjugates as intracellular gene control agents.
Gabriela D Ivanova, Martin M Fabani, Andrey A Arzumanov, Rachida Abes, Haifang Yin

Nucleic Acids Symp Ser (Oxf)· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient inhibition of miR-155 function in vivo by peptide nucleic acids.
Martin M Fabani, Cei Abreu-Goodger, Donna Williams, Paul A Lyons, Adrian G Torres

Nucleic Acids Res· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator.
Dimitrios Lagos, Gabriel Pollara, Stephen Henderson, Fiona Gratrix, Martin Fabani

Nat Cell Biol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates.
Martin M Fabani, Michael J Gait

RNA· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.
John J Turner, Simon Jones, Martin M Fabani, Gabriela Ivanova, Andrey A Arzumanov

Blood Cells Mol Dis· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligonucleotide analogs as antiviral agents.
Martin M Fabani, John J Turner, Michael J Gait

Curr Opin Mol Ther· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the HIV-1 RNA leader sequence with synthetic oligonucleotides and siRNA: chemistry and cell delivery.
John J Turner, Martin Fabani, Andrey A Arzumanov, Gabriela Ivanova, Michael J Gait

Biochim Biophys Acta· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence-specific artificial ribonucleases. I. Bis-imidazole-containing oligonucleotide conjugates prepared using precursor-based strategy.
Natalia G Beloglazova, Martin M Fabani, Marina A Zenkova, Elena V Bichenkova, Nikolai N Polushin

Nucleic Acids Res· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis